Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BY-02

Home DrugsBY-02

BY-02

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

MODULATION OF TUMOR IMMUNITY BY PROTEIN-MEDIATED 02 DELIVERY
Applicant: OMNIOX INCPriority: 2015
CN
Application of phytobacterium plantarum chen-02 in preparation of medicine for improving intestinal dysfunction caused by burn
Applicant: UNIV NANCHANGPriority: 2025
CN
Application of TA-02 in cardiac transplantation rejection by regulating and controlling immune function of dendritic cells
Applicant: UNION HOSPITAL TONGJI MEDICAL COLLEGE HUAZHONG UNIV SCI & TECHPriority: 2025
CN
Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
Applicant: IMMATICS BIOTECHNOLOGIES GMBHPriority: 2020
CN
US
6 publications
Amidated peptides and deamidated counterparts thereof shown by non-hla-a*02 for immunotherapy of different types of cancer
Applicant: IMATIX BIOTECH LTDPriority: 2021
CN
Amidated peptides and their deamidated counterparts displayed by non-HLA-a*02 for use in immunotherapy against different types of cancers
Applicant: IMMATICS BIOTECHNOLOGIES GMBHPriority: 2021
US
5 publications
Application of clostridium butyricum NCU-02 in preparation of medicine for improving hyperlipemia and/or autism
Applicant: UNIV NANCHANGPriority: 2025
CN
Application of streptococcus thermophilus CT-02 in preparation of product for relieving pollen-induced allergic rhinitis
Applicant: KASHI DAIRY SHENZHEN CO LTDPriority: 2026
CN